| Bioactivity | VU0364572 is a selective allosteric agonist of the M1 muscarinic receptor with an EC50 of 0.11 μM. VU0364572 has neuroprotective potential for preventing memory impairments and reducing neuropathology in Alzheimer’s Disease. VU0364572 is orally active and is CNS penetrant[1][3]. |
| Invitro | VU0364572 (30 μM; 25 min) 促进 striatal/NAc 切片中 KCNQ2、NR1 和 MARCKS 的磷酸化[2]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. 0 --> VU0364572 相关抗体: |
| In Vivo | VU0364572 (10 mg/kg/day; oral; 4 months) TFA 在 5XFAD 转基因阿尔茨海默氏症小鼠中显示出神经保护作用。VU0364572 的半衰期为 45 分钟[1]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. |
| CAS | 1240514-87-7 |
| Formula | C21H31N3O3 |
| Molar Mass | 373.49 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Lebois EP, et al. Disease-Modifying Effects of M1 Muscarinic Acetylcholine Receptor Activation in an Alzheimer's Disease Mouse Model. ACS Chem Neurosci. 2017 Jun 21;8(6):1177-1187. [2]. Faruk MO, et al. Muscarinic signaling regulates voltage-gated potassium channel KCNQ2 phosphorylation in the nucleus accumbens via protein kinase C for aversive learning. J Neurochem. 2022 Feb;160(3):325-341. [3]. Lebois EP, et al. Development of a highly selective, orally bioavailable and CNS penetrant M1 agonist derived from the MLPCN probe ML071. Bioorg Med Chem Lett. 2011 Nov 1;21(21):6451-5. |
VU0364572
CAS: 1240514-87-7 F: C21H31N3O3 W: 373.49
VU0364572 is a selective allosteric agonist of the M1 muscarinic receptor with an EC50 of 0.11 μM. VU0364572 has neurop
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.